Hotchkis & Wiley Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $642M | Buy |
2,191,563
+140,413
| +7% | +$46.1M | 1.98% | 12 |
|
|
2025
Q4 | $719M | Buy |
2,051,150
+5,670
| +0.3% | +$1.92M | 2.15% | 11 |
|
|
2025
Q3 | $661M | Buy |
2,045,480
+627,038
| +44% | +$195M | 2.04% | 8 |
|
|
2025
Q2 | $552M | Sell |
1,418,442
-359,142
| -20% | -$144M | 1.79% | 11 |
|
|
2025
Q1 | $773M | Buy |
1,777,584
+1,972
| +0.1% | +$792K | 2.58% | 6 |
|
|
2024
Q4 | $655M | Buy |
1,775,612
+532,611
| +43% | +$223M | 2.18% | 7 |
|
|
2024
Q3 | $646M | Sell |
1,243,001
-70,578
| -5% | -$37.7M | 2.15% | 8 |
|
|
2024
Q2 | $712M | Sell |
1,313,579
-186,960
| -12% | -$98.8M | 2.48% | 7 |
|
|
2024
Q1 | $778M | Sell |
1,500,539
-113,791
| -7% | -$56.6M | 2.59% | 7 |
|
|
2023
Q4 | $761M | Sell |
1,614,330
-108,477
| -6% | -$50.2M | 2.71% | 5 |
|
|
2023
Q3 | $750M | Buy |
1,722,807
+133,453
| +8% | +$60.5M | 2.85% | 6 |
|
|
2023
Q2 | $706M | Buy |
1,589,354
+298,562
| +23% | +$138M | 2.62% | 5 |
|
|
2023
Q1 | $594M | Buy |
1,290,792
+492,237
| +62% | +$234M | 2.29% | 8 |
|
|
2022
Q4 | $410M | Sell |
798,555
-279,687
| -26% | -$142M | 1.57% | 18 |
|
|
2022
Q3 | $490M | Sell |
1,078,242
-164,088
| -13% | -$78.5M | 2.1% | 10 |
|
|
2022
Q2 | $600M | Sell |
1,242,330
-478,177
| -28% | -$237M | 2.38% | 8 |
|
|
2022
Q1 | $845M | Sell |
1,720,507
-376,181
| -18% | -$172M | 2.69% | 6 |
|
|
2021
Q4 | $972M | Sell |
2,096,688
-286,740
| -12% | -$121M | 3.06% | 5 |
|
|
2021
Q3 | $889M | Sell |
2,383,428
-68,916
| -3% | -$26.2M | 2.84% | 5 |
|
|
2021
Q2 | $936M | Sell |
2,452,344
-156,294
| -6% | -$59.7M | 2.85% | 5 |
|
|
2021
Q1 | $936M | Buy |
2,608,638
+300,302
| +13% | +$96.6M | 2.85% | 5 |
|
|
2020
Q4 | $741M | Buy |
2,308,336
+252,647
| +12% | +$77.5M | 2.59% | 6 |
|
|
2020
Q3 | $552M | Buy |
2,055,689
+388,905
| +23% | +$105M | 2.51% | 7 |
|
|
2020
Q2 | $438M | Buy |
1,666,784
+5,890
| +0.4% | +$1.57M | 2.04% | 10 |
|
|
2020
Q1 | $377M | Buy |
1,660,894
+396,620
| +31% | +$108M | 2.12% | 10 |
|
|
2019
Q4 | $382M | Buy |
1,264,274
+96,973
| +8% | +$26.7M | 1.33% | 26 |
|
|
2019
Q3 | $280M | Buy |
1,167,301
+309,390
| +36% | +$84.8M | 1.13% | 32 |
|
|
2019
Q2 | $242M | Buy |
857,911
+292,610
| +52% | +$79.9M | 0.93% | 39 |
|
|
2019
Q1 | $162M | Sell |
565,301
-18,469
| -3% | -$5.34M | 0.64% | 45 |
|
|
2018
Q4 | $153M | Sell |
583,770
-612,522
| -51% | -$168M | 0.68% | 45 |
|
|
2018
Q3 | $328M | Sell |
1,196,292
-108,584
| -8% | -$28.2M | 1.18% | 30 |
|
|
2018
Q2 | $311M | Sell |
1,304,876
-26,925
| -2% | -$6.24M | 1.17% | 30 |
|
|
2018
Q1 | $293M | Sell |
1,331,801
-134,917
| -9% | -$31.7M | 1.16% | 34 |
|
|
2017
Q4 | $330M | Sell |
1,466,718
-927,092
| -39% | -$197M | 1.25% | 26 |
|
|
2017
Q3 | $455M | Buy |
2,393,810
+12,975
| +0.5% | +$2.47M | 1.79% | 16 |
|
|
2017
Q2 | $448M | Sell |
2,380,835
-1,169,135
| -33% | -$210M | 1.8% | 16 |
|
|
2017
Q1 | $587M | Sell |
3,549,970
-85,597
| -2% | -$13.6M | 2.3% | 10 |
|
|
2016
Q4 | $523M | Sell |
3,635,567
-71,746
| -2% | -$9.61M | 2.11% | 10 |
|
|
2016
Q3 | $465M | Buy |
3,707,313
+1,241,762
| +50% | +$160M | 1.94% | 12 |
|
|
2016
Q2 | $324M | Buy |
2,465,551
+176,293
| +8% | +$24.1M | 1.38% | 24 |
|
|
2016
Q1 | $318M | Sell |
2,289,258
-94,128
| -4% | -$12.6M | 1.34% | 24 |
|
|
2015
Q4 | $332M | Buy |
2,383,386
+58,018
| +2% | +$7.99M | 1.35% | 23 |
|
|
2015
Q3 | $326M | Buy |
2,325,368
+869,193
| +60% | +$131M | 1.3% | 26 |
|
|
2015
Q2 | $239M | Sell |
1,456,175
-831,182
| -36% | -$133M | 0.84% | 43 |
|
|
2015
Q1 | $353M | Sell |
2,287,357
-418,979
| -15% | -$59.7M | 1.23% | 27 |
|
|
2014
Q4 | $340M | Buy |
2,706,336
+17,920
| +0.7% | +$2.21M | 1.19% | 28 |
|
|
2014
Q3 | $322M | Sell |
2,688,416
-828,772
| -24% | -$95.1M | 1.17% | 28 |
|
|
2014
Q2 | $378M | Buy |
3,517,188
+220,501
| +7% | +$22.7M | 1.34% | 26 |
|
|
2014
Q1 | $328M | Buy |
3,296,687
+281,541
| +9% | +$25.5M | 1.22% | 29 |
|
|
2013
Q4 | $279M | Sell |
3,015,146
-94,133
| -3% | -$8.36M | 1.19% | 30 |
|
|
2013
Q3 | $260M | Sell |
3,109,279
-48,620
| -2% | -$4.17M | 1.2% | 29 |
|
|
2013
Q2 | $258M | Buy |
+3,157,899
| New | +$236M | 1.29% | 29 |
|
Other funds holding ELV
VCM
VPM
Hotchkis & Wiley Capital Management's ELV Position: Q1 2026 in Review
Hotchkis & Wiley Capital Management increased its Elevance Health (ELV) stake by 6.8% in Q1 2026, buying an estimated $46.1M and bringing the position to 2,191,563 shares worth $642M. The position accounts for 1.98% of the portfolio, ranked #12.
Hotchkis & Wiley Capital Management first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $972M in Q4 2021. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Hotchkis & Wiley Capital Management held 2,191,563 shares of Elevance Health worth $642M as of Q1 2026.
- Hotchkis & Wiley Capital Management bought 140,413 Elevance Health shares in Q1 2026, an estimated $46.1M.
- Elevance Health made up 1.98% of Hotchkis & Wiley Capital Management's portfolio in Q1 2026, its #12 holding.
- Hotchkis & Wiley Capital Management first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Hotchkis & Wiley Capital Management's Elevance Health position peaked at $972M in Q4 2021.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Hotchkis & Wiley Capital Management's 13F filing for Q1 2026, filed 15 May 2026.